Skip to main content
TipRanks
Go Ultimate75% OFF

Recce Pharmaceuticals Ltd. (RCE) Stock Statistics & Valuation Metrics

23 Followers

Total Valuation

Recce Pharmaceuticals Ltd. has a market cap or net worth of AUD 111.63M. The enterprise value is AUD 124.87M.

Market Cap
AUD 111.63M
Enterprise Value
AUD 124.87M

Share Statistics

Recce Pharmaceuticals Ltd. has 305,844,100 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
305,844,100
Owned by Insiders
2.56%
Owned by Institutions
―

Financial Efficiency

Recce Pharmaceuticals Ltd.’s return on equity (ROE) is 0.89 and return on invested capital (ROIC) is 238.75%.

Return on Equity (ROE)
0.89
Return on Assets (ROA)
-1.75
Return on Invested Capital (ROIC)
238.75%
Return on Capital Employed (ROCE)
2.97
Revenue Per Employee
0
Profits Per Employee
-1.87M
Employee Count
8
Asset Turnover
0.00
Inventory Turnover
0.00

Valuation Ratios

The current PE Ratio of Recce Pharmaceuticals Ltd. is -7.14. Recce Pharmaceuticals Ltd.’s PEG ratio is -0.39.

PE Ratio
-7.14
PS Ratio
0.00
PB Ratio
-6.40
Price to FCF
-11.37
Price to Operating Cash Flow
-10.82
PEG Ratio
-0.39

Income Statement

In the last 12 months, Recce Pharmaceuticals Ltd. had revenue of 0 and earned -14.96M in profits. Earnings per share was -0.05.

Revenue
0
Gross Profit
-356.40K
Operating Income
-23.16M
Pretax Income
-23.84M
Net Income
-14.96M
EBITDA
-22.81M
Earnings Per Share (EPS)
-0.05

Cash Flow

In the last 12 months, operating cash flow was -9.89M and capital expenditures -61,964, giving a free cash flow of -9.95M billion.

Operating Cash Flow
-9.89M
Free Cash Flow
-9.95M
Free Cash Flow per Share
-0.03

Dividends & Yields

Recce Pharmaceuticals Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
-8.80%
Earnings Yield
-13.98%

Stock Price Statistics

Beta
1.19
52-Week Price Change
-16.85%
50-Day Moving Average
0.33
200-Day Moving Average
0.43
Relative Strength Index (RSI)
61.50
Average Volume (3m)
260.24K

Important Dates

Recce Pharmaceuticals Ltd. upcoming earnings date is Mar 01, 2027, TBA (Not Confirmed).

Last Earnings Date
Aug 31, 2026
Next Earnings Date
Mar 01, 2027
Ex-Dividend Date
―

Financial Position

Recce Pharmaceuticals Ltd. as a current ratio of 0.44, with Debt / Equity ratio of -62.44%

Current Ratio
0.44
Quick Ratio
0.44
Debt to Market Cap
0.09
Net Debt to EBITDA
-0.34
Interest Coverage Ratio
-13.96

Taxes

In the past 12 months, Recce Pharmaceuticals Ltd. has paid -8.88M in taxes.

Income Tax
-8.88M
Effective Tax Rate
0.37

Enterprise Valuation

Recce Pharmaceuticals Ltd. EV to EBITDA ratio is -5.41, with an EV/FCF ratio of -12.15.

EV to Sales
0.00
EV to EBITDA
-5.41
EV to Free Cash Flow
-12.15
EV to Operating Cash Flow
-12.22

Balance Sheet

Recce Pharmaceuticals Ltd. has AUD 2.69M in cash and marketable securities with AUD 10.44M in debt, giving a net cash position of -AUD 7.75M billion.

Cash & Marketable Securities
AUD 2.69M
Total Debt
AUD 10.44M
Net Cash
-AUD 7.75M
Net Cash Per Share
-AUD 0.03
Tangible Book Value Per Share
-AUD 0.06

Margins

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

Gross Margin
0.00%
Operating Margin
0.00%
Pretax Margin
0.00%
Net Profit Margin
0.00%
EBITDA Margin
0.00%
EBIT Margin
0.00%

Analyst Forecast

The average price target for Recce Pharmaceuticals Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target
―
Price Target Upside
―
Analyst Consensus
―
Analyst Count
―
Revenue Growth Forecast
―
EPS Growth Forecast
42.51%

Scores

Smart Score
7
AI Score
47